Bondlido, a prescription medicine containing lidocaine, is primarily used by adults to relieve the unique pain known as postherpetic neuralgia—the lingering nerve pain after healing from shingles. As a topical patch, it provides local pain relief by numbing the affected area. But, like any medication, Bondlido comes with potential side effects, drug interactions, and important …
Introduction: A New Era in Keratoconus Management Keratoconus is a progressive eye disorder that causes the cornea – the transparent front part of the eye – to thin and take on a cone-like shape. This degeneration causes blurred vision, light sensitivity and, in advanced stages, possible vision loss. For decades, ophthalmologists have been searching for …
Introduction Denosumab is a potent monoclonal antibody that is widely used to treat bone-loss conditions such as osteoporosis, bone metastases, and bone complications associated with cancer. It works by inhibiting osteoclast activity, which reduces bone resorption and improves bone density. Although denosumab has been shown to be highly effective, patients and healthcare professionals should be …
Introduction: Understanding How Long Does Lidocaine Injection Last in Skin If you’ve ever had minor surgery, a skin biopsy, a tattoo, or a dental procedure, you’ve probably experienced the numbing effects of lidocaine. It’s the most widely used local anesthetic in medicine today. But a common question patients and doctors ask is – how long …
Introduction: Breathing New Life into Pulmonary Fibrosis Treatment Progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF) are chronic, life-limiting lung diseases that make it increasingly difficult to breathe. For decades, patients had limited treatment options, primarily pirfenidone and nintedanib, both of which slow – but do not stop – the progression of the disease. …
Introduction Lung cancer is a leading cause of cancer-related deaths worldwide. Of its types, non-small cell lung cancer (NSCLC) accounts for nearly 85% of all lung cancer cases. Over the past decade, understanding the molecular pathways involved in cancer progression has opened new doors for targeted therapies. One of the most exciting advances in this …
Introduction: A Milestone in Allergy Treatment On September 30, 2025, the US Food and Drug Administration (FDA) approved remibrutinib, marketed under the brand name Rapsido, for adult patients with chronic spontaneous urticaria (CSU) who are not responding to treatment with H1 antihistamines. This approval is a significant milestone, as remibrutinib becomes the first oral Bruton’s …
Brinsupri, marketed under the brand name Brensocatib, represents a major advance in respiratory medicine. In August 2025, the US Food and Drug Administration (FDA) approved this first-in-class oral drug for the treatment of non-cystic fibrosis bronchiectasis (NCFB) – a chronic, inflammatory lung condition that has long lacked targeted treatment options. This approval is an important …
Introduction The Elamipretide FDA Approval is a revolutionary step in the treatment of one of the world’s rarest and most devastating mitochondrial diseases – Barth syndrome. After years of research, advocacy and clinical trials, the US Food and Drug Administration has granted accelerated approval to Forzinity (elamipretide) injection, making it the first approved therapy for …
Highlights What Is Imlunestrant? Imlunstrant , marketed under the brand name Inlurio, is an oral selective estrogen receptor degrader (SERD) developed by Eli Lilly & Company. It is a next-generation endocrine therapy specifically designed for postmenopausal women and men with ER-positive, HER2-negative breast cancer that harbors ESR1 mutations. Unlike older SERDs that require injections, Imlunstrant …
